| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.00016 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.00014 | 1 |